RENAL-CELL CARCINOMA EXTENDING INTO THE VENA-CAVA - A MULTIINSTITUTE STUDY

被引:0
|
作者
OZONO, S
OKAJIMA, E
TSUKAMOTO, T
KUMAMOTO, Y
NEMOTO, R
UCHIDA, K
KOISO, K
KAWAMURA, N
AKIMOTO, M
KAKEHI, Y
YOSHIDA, O
USAMI, M
KOTAKE, T
机构
关键词
RENAL CELL CARCINOMA; VENA CAVAL THROMBUS; SURVIVAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present paper reports the clinical results from cases of renal cell carcinoma with vena caval tumor thrombus. Fifty patients were entered into the study between 1980 and 1989. The primary tumor and vena caval tumor thrombus were completely removed in 39 (78%) patients, and 41 (82%) received postoperative treatment. The overall 12-, 36-, 60- and 90-month actuarial survival rates were 72, 41, 19 and 10%, respectively. Only tumor stage affected survival, however, other factors such as tumor grade, nodal status, metastatic status and level of vena caval involvement not affecting it. Postoperative interferon (IFN) treatment affected survival, whereas degree of curative surgery did not. The results of our study were, however, examined retrospectively in several institutes. Further investigation of the postoperative treatment for renal cell carcinoma with vena caval tumor thrombus will be necessary.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 50 条
  • [31] PROGNOSTIC FACTORS IN RENAL-CELL CARCINOMA
    LANIGAN, D
    BRITISH JOURNAL OF UROLOGY, 1995, 75 (05): : 565 - 571
  • [32] Improving surgical outcomes in renal cell carcinoma involving the inferior vena cava
    Gonzalez, Javier
    Andres, Guillermo
    Ignacio Martinez-Salamanca, Juan
    Ciancio, Gaetano
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (12) : 1373 - 1387
  • [33] Hypofractionated radiotherapy for renal cell carcinoma with inferior vena cava tumour thrombus
    Beldzinska, Karolina
    Gadek, Konrad
    Rutkowski, Jacek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (04): : 310 - 313
  • [34] Incidental Finding of Renal Cell Carcinoma: Detected by a Thrombus in the Inferior Vena Cava
    Bellman, Nancy L.
    JOURNAL OF DIAGNOSTIC MEDICAL SONOGRAPHY, 2015, 31 (02) : 118 - 121
  • [35] Surgical management of renal cell carcinoma (RCC) with vena cava tumour thrombus
    Belgrano, E
    Trombetta, C
    Siracusano, S
    Carmignani, G
    Martorana, G
    Liguori, G
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (08) : 610 - 618
  • [36] Trends and outcomes in contemporary management renal cell carcinoma and vena cava thrombus
    Beksac, Alp Tuna
    Shah, Qainat N.
    Paulucci, David J.
    Lo, Jing Zhi
    Okhawere, Kennedy E.
    Elbakry, Amr A.
    Dayal, Bheesham D.
    Mehrazin, Reza
    Eun, Daniel
    Hemal, Ashok
    Abaza, Ronney
    Sfakianos, John P.
    Badani, Ketan K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 576.e17 - 576.e23
  • [37] RENAL-CELL CARCINOMA EXTENDING INTO THE RIGHT VENTRICLE - SUCCESSFUL RESECTION WITH CARDIOPULMONARY BYPASS
    REDAELLI, C
    CARREL, T
    JENNI, R
    STOFFEL, P
    TURINA, M
    THORACIC AND CARDIOVASCULAR SURGEON, 1992, 40 (02) : 102 - 104
  • [38] A Contemporary Clinicopathologic Analysis of Patients With Renal Cell Carcinoma and Vena Cava Involvement
    Al-Rusan, Omar M.
    Patil, Dattatraya
    Master, Viraj A.
    Osunkoya, Adeboye O.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (02) : 279 - 285
  • [39] Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma
    Ficarra, V
    Righetti, R
    D'Amico, A
    Rubilotta, E
    Novella, G
    Malossini, G
    Mobilio, G
    ONCOLOGY, 2001, 61 (01) : 10 - 15
  • [40] Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava
    Tanaka, Yoshimi
    Hatakeyama, Shingo
    Hosogoe, Shogo
    Tanaka, Toshikazu
    Hamano, Itsuto
    Kusaka, Ayumu
    Iwamura, Hiromich
    Fujita, Naoki
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 134 - 141